# Once-Weekly Semaglutide in Adults with Overweight or Obesity

Article · John P.H. Wilding, Rachel Louise Batterham, Salvatore Calanna, Melanie Jane Davies, Luc F. Van Gaal, Ildiko Lingvay, Barbara M. McGowan, Julio Rosenstock, Marie Thi Dao Tran, Thomas A. Wadden, Sean Wharton, Koutaro Yokote, Niels Zeuthen, Robert F. Kushner

- Archive id: doi:10.1056/nejmoa2032183
- Published: 2021-02-10
- Venue: New England Journal of Medicine
- DOI: https://doi.org/10.1056/nejmoa2032183
- PMID: 33567185
- Citations: 5,188
- Source URL: https://doi.org/10.1056/nejmoa2032183
- PDF: https://discovery.ucl.ac.uk/10127569/1/nejmoa2032183.pdf
- Provenance: openalex

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [GLP-1 & Incretin Therapies](https://space-kitty.com/topics/glp1-metabolic)

Cited in dossiers:
- [GLP-1 & Incretin Therapies: State of the Field (October 2026)](https://space-kitty.com/dossiers/glp1-metabolic)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.